Fact CheckerSign in

NCT05836194Completed

Evaluation of Diabetic Retinopathy Using Ultra-Widefield Fundus Images Compared With Two-Field Fundus Images

Comparison of Ultra-Widefield Scanning Laser Ophthalmoscopy and Two-Field Fundus Photography for Evaluating Diabetic Retinopathy

Source: ClinicalTrials.gov · Last updated 22 Aug 2024

Brief summary (registry, in English)

This study aims to compare the accuracy of evaluating diabetic retinopathy using ultra-widefield fundus images versus two-field fundus images. The hypothesis is that screening and grading diabetic retinopathy based on ultra-widefield fundus images may yield higher accuracy compared to the use of two-field fundus images.

Status (registry)
Completed
Study type
Observational
Enrollment
769 (actual)
First submitted
18 Apr 2023
Start date
1 Oct 2022
Primary completion date
30 Sept 2023
Lead sponsor
Ningbo Eye Hospital
NCT number
NCT05836194

What you commit to

  • Study type: Observational
  • Participants enrolled: 769
  • From 1 Oct 2022 to the primary completion date, 30 Sept 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of panretinal laser photocoagulation.

Age

  • Diseases involving the posterior pole other than DR, such as age-related macular degeneration,retinal vein occlusion.

Who the study is looking for

  • Age 18 years or older.
  • Diagnosis of diabetes mellitus.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ningbo Eye Hospital
Coordinator of this site? Confirm its status
NingboChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.